Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,841,255
-
Number of holders
-
745
-
Total 13F shares, excl. options
-
74,418,598
-
Shares change
-
-530,894
-
Total reported value, excl. options
-
$19,431,403,452
-
Value change
-
-$142,779,457
-
Put/Call ratio
-
249%
-
Number of buys
-
306
-
Number of sells
-
-297
-
Price
-
$261.13
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2019
820 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2019.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 745 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,418,598 shares
of 80,841,255 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,449,818 shares), BlackRock Inc. (7,424,845 shares), Fundsmith LLP (4,591,899 shares), STATE STREET CORP (3,771,848 shares), BAMCO INC /NY/ (3,770,057 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,638,135 shares), GEODE CAPITAL MANAGEMENT, LLC (1,551,666 shares), BLAIR WILLIAM & CO/IL (1,545,980 shares), Neuberger Berman Group LLC (1,229,832 shares), and PRINCIPAL FINANCIAL GROUP INC (1,195,241 shares).
This table shows the top 745 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.